Irinotecan HCl for Injection

Product description

The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.

Strength: 40mg/2ml; 100mg/5ml.

CFDA approved. MA issued from US-FDA, Japanese PMDA.
Read more

Specifications

Categories Finished Dosage FormsPowders; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Irinotecan HCl for Injection

Contact information

Address

Telephone

Website

View all contact information